GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...
Protect process intelligence early. Treat pilot‑plant data and digital recipes as crown jewels, and design access, logging, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback